ACROBAT

NEWBORNS

APPRAISING THE CRITICAL ROLE OF PROGNOSTIC BIOMARKERS IN THE ASSESSMENT AND TRIAGE OF SICK AFRICAN NEWBORNS

WHERE?

Neonatal sepsis is a major cause of preventable mortality globally, with up to 5 million cases and 800,000 deaths each year, mostly in Sub-Saharan Africa.

THE PROJECT
IN NUMBERS:

0
partners
0
hospitals
0
newborns to be recruited

THE TEST

A rapid point-of-care test that measures blood biomarker levels in less than 20 min.

Triage should not be a guessing game.

Improving decision-making anywhere at any time.

TEAM

ISGlobal
FUNDAÇAO MANHIÇA (FM) – Centro de Investigação em Saúde de Manhiça (CISM)
Global Health Uganda Limited
Haramaya University
Centre de Recherches Médicales de Lambaréné
Universidade Eduardo Mondlane (UEM), Faculty of Medicine
Hutzpa Consulting and Innovation Lab
BioEclosion SL
Institute for Tropical Medicine, Travel Medicine and Human Parasitology of the University Clinic Tuebingen
Institute for Tropical Medicine, Travel Medicine and Human Parasitology of the University Clinic Tuebingen
London School of Hygiene and Tropical Medicine

We are developing a rapid test to predict severe disease regardless of the infection to be used where newborns need it the most

PARTNER PROJECT

We have a partner project,
EChiLiBRiST for older children.

Enhancing children’s lives with biomarkers for risk stratification and Triage

PARTNER PROJECT

We have a partner project,
EChiLiBRiST in older children.

Enhancing children’s lives with biomarkers for risk stratification and Triage